Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing
18/08/2026 22:15
BRIEF-TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing Aug 18 (Reuters) - Amgen Inc AMGN.O:
TSCAN THERAPEUTICS - AMGEN TO TERMINATE RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH TSCAN THERAPEUTICS - SEC FILING
TSCAN THERAPEUTICS - TERMINATION OF COLLABORATION AGREEMENT EFFECTIVE NOVEMBER 10, 2026 - SEC FILING
Source text: [ID:n0001193125-26-355664]
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing